Premium
A dual pathway inhibition strategy using BKM120 combined with vemurafenib is poorly tolerated in BRAF V600 E/K mutant advanced melanoma
Author(s) -
Algazi Alain Patrick,
Rotow Julia,
Posch Christian,
OrtizUrda Susana,
Pelayo Alyson,
Munster Pamela N.,
Daud Adil
Publication year - 2019
Publication title -
pigment cell and melanoma research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.618
H-Index - 105
eISSN - 1755-148X
pISSN - 1755-1471
DOI - 10.1111/pcmr.12777
Subject(s) - vemurafenib , mutant , cancer research , melanoma , mutation , chemistry , metastatic melanoma , computational biology , medicine , biology , biochemistry , gene